Skip to main content
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · TARS ISIN · US87650L1035 US Manufacturing
Open in API
Filings indexed 576 across all filing types
Latest filing 2023-06-27 Declaration of Voting R…
Country US United States of America
Listing US TARS

About Tarsus Pharmaceuticals, Inc.

https://www.tarsusrx.com/

Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 22, 2023. It details the submission of matters to a vote of security holders at the company's Annual Meeting of Stockholders, including election results of directors and ratification of the independent auditor. The content focuses on official voting results from the shareholder meeting. There is no full annual report, financial statements, or management discussion. The document is not a proxy statement or solicitation but reports the voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 5447 characters, sufficient to contain detailed voting results rather than a brief announcement. Therefore, the classification is DVA with high confidence.
2023-06-27 English
FORM 4
Director's Dealing
2023-06-27 English
FORM 4
Director's Dealing
2023-06-26 English
FORM 4
Director's Dealing
2023-06-26 English
FORM 4
Director's Dealing
2023-06-26 English
FORM 4
Director's Dealing
2023-06-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.